Equity Research, Broker Reports, and media content on Novacyt SAS

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Novacyt SAS
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Novacyt SAS

Company Profile

  • Personnel
  • Anthony Dyer, CFO
  • Graham Mullis, CEO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Novacyt SAS. We currently have 75 research reports from 4 professional analysts.

Date Source Announcement
13May22 07:00 RNS Novacyt S.A. - Notice of Annual General Meeting
03May22 12:21 RNS Novacyt S.A. - Liquidity Agreement Update and Total Voting Rights
28Apr22 07:00 RNS Novacyt S.A. - Full year results and update on growth strategy
26Apr22 07:00 RNS Novacyt S.A. - DHSC dispute update
20Apr22 07:00 RNS Novacyt S.A. - Notice of Results and Investor Presentation
12Apr22 07:00 RNS Novacyt S.A. - Approval of COVID-19 test under CTDA legislation
01Apr22 11:45 RNS Novacyt S.A. - Liquidity Agreement Update and Total Voting Rights
  • Frequency of research reports

     

  • Research reports on

    Novacyt SAS

  • Providers covering

    Novacyt SAS

Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics. The company trades under the ticker Lon:NCYT